NFKB1 and synovial sarcoma: In synovial sarcoma cells, we findthat nuclear levels of the RelA subunit of NF-κB increase during MS-275 treatment, butdecrease in the presence of 17-AAG as a single agent or in combination withMS-275 (Figure 3).